Obermeyer S, Mielke RT, Lederhos HL. The Role of Perinatal Nurses in the Use of Tranexamic Acid During Postpartum Hemorrhage.
Nurs Womens Health 2022;
26:63-71. [PMID:
35065079 DOI:
10.1016/j.nwh.2021.12.003]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 07/10/2021] [Accepted: 12/08/2021] [Indexed: 06/14/2023]
Abstract
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide. Mitigation of PPH is dependent on identification of risk, readiness, timely identification of hemorrhage, accurate determination of blood loss, and effective treatment. Perinatal nurses must be prepared to participate in all these aspects of care, including the use of tranexamic acid, an antifibrinolytic agent that has more recently been added to the pharmacologic agents used to reduce blood loss associated with hemorrhage. The purpose of this article is to identify the nurse's role in the management of PPH and to introduce the use of tranexamic acid in PPH management as part of the nurse's role in implementing best practices for PPH.
Collapse